Safety Evaluation The FAA evaluates whether a medication could impair judgment, reaction time, cognition, vision, coordination, or overall flight safety
Tirzepatide is a first-of-its-kind dual-action peptide that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors
GLP-1s reduce liver glucose production, too. While many of the benefits do overlap, each class of drugs offers different benefits
This gradual titration was specifically designed to mitigate the nausea, vomiting, and diarrhea that occur more frequently with rapid dose increases
It may be extremely itchy, which is a sign of healing
doi:10.7759/cureus.101693 Min JS, Jo SJ, Lee S, et al